Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
111.51B
Market cap111.51B
Price-Earnings ratio
38.35
Price-Earnings ratio38.35
Dividend yield
Dividend yield
Average volume
15.00M
Average volume15.00M
High today
$75.82
High today$75.82
Low today
$73.81
Low today$73.81
Open price
$74.64
Open price$74.64
Volume
14.19M
Volume14.19M
52 Week high
$109.50
52 Week high$109.50
52 Week low
$72.69
52 Week low$72.69

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $75.82. The company's market cap stands at 111.51B, with a P/E ratio of 38.35.

On 2026-02-24, Boston Scientific(BSX) stock moved within a range of $73.81 to $75.82. With shares now at $75.82, the stock is trading +2.7% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 14.19M, compared to an average daily volume of 15M.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $72.69.

Over the past 52 weeks, Boston Scientific(BSX) stock has traded between a high of $109.50 and a low of $72.69.

BSX News

TipRanks 1h
Belo Sun Raises US$30 Million and Welcomes La Mancha as New Control Shareholder

An announcement from Belo Sun Mining ( (TSE:BSX) ) is now available. Belo Sun Mining has closed a non-brokered private placement raising US$30 million (C$41.3...

Simply Wall St 10h
Is Boston Scientific Offering Value After Recent Share Price Pullback

If you are wondering whether Boston Scientific is fairly priced or offering value at current levels, this article will walk through what the numbers are actuall...

Is Boston Scientific Offering Value After Recent Share Price Pullback
TipRanks 2d
Boston Scientific names Cathy Smith, Christophe Weber to board of directors

Boston Scientific (BSX) announced the election of Cathy Smith and Christophe Weber to its Board of Directors, effective February 18. Smith currently serves as C...

Analyst ratings

97%

of 36 ratings
Buy
97.2%
Hold
2.8%
Sell
0%

More BSX News

TipRanks 4d
Boston Scientific’s TheraSphere Trial in Japan Signals New Growth Path in Liver Cancer

Boston Scientific (BSX) announced an update on their ongoing clinical study. Boston Scientific (BSX) is running the TheraSphere Japan Pre-Market Study to test...

Simply Wall St 7d
Boston Scientific Tests Combined Cardiac Devices In OPTION EMEA Trial

Boston Scientific (NYSE:BSX) has started the OPTION-EMEA clinical trial in real world hospital settings across Europe. The study evaluates the combined use of...

Boston Scientific Tests Combined Cardiac Devices In OPTION EMEA Trial

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.